Reckitt Benckiser stock falls nearly 2% as Mead Johnson launches tender offer for senior notes

Reckitt Benckiser stock falls nearly 2% as Mead Johnson launches tender offer for senior notes
Reckitt benckiser slides 1.61% today

Reckitt Benckiser Group plc (RKT) fell 1.61% after the launch of a tender offer by its subsidiary Mead Johnson Nutrition to purchase outstanding senior notes and amend the associated indenture. The move remains pressured, with the price action limited as RKT trades above its 20- and 50-day moving averages but below the 200-day, highlighting ongoing longer-term weakness.

RKT price prediction
24H -0.37%
GBX 5,681
48H -0.32%
GBX 5,684
7D 0.37%
GBX 5,723
1M 7.7%
GBX 6,141
3M -5.81%
GBX 5,370.88
6M -18.37%
GBX 4,654.41
12M -22.61%
GBX 4,412.89
Current price: GBX 5,702 34.00 0.60%
Closed 11/13
Daily range 5652.00 Arrow from to Icon 5716.00
Weekly range 5574.00 Arrow from to Icon 5728.00
Loading...

Highlights

  • Mead Johnson Nutrition, owned by Reckitt Benckiser, initiated a cash tender for all $500 million 4.6% senior notes due 2044, seeking to remove restrictive covenants and Reckitt’s guarantee.
  • Reckitt Benckiser remains active across its core consumer goods categories but its stock faces sustained selling pressure.
  • Reckitt Benckiser stock trades above key short- and medium-term averages, with technical indicators signaling overbought conditions; forecasted five-day range is GBX5,133 to GBX5,379, with a high probability of an upward move.

Selling pressure builds as covenants removed in bond deal

Mead Johnson Nutrition Company, a wholly-owned subsidiary of Reckitt Benckiser, launched a cash tender offer for all of its $500 million 4.600% senior notes due 2044, with a related consent solicitation to amend the indenture and remove most restrictive covenants, certain events of default, and Reckitt's guarantee. The company also has an upcoming ex-dividend date on August 6 for a dividend of 0.886 GBX. Reckitt Benckiser was reported active in its core consumer goods segment, producing and marketing cleaning, personal care, and OTC products, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, is cautious on Reckitt Benckiser. He sees the technical setup as fragile, with persistent underperformance below the 200-day moving average signaling unresolved long-term weakness. The tender offer and proposed removal of restrictive covenants do not offset concerns about falling momentum and overbought signals. The closing near session lows and a downside gap reflect defensive market sentiment. "Short-term support may hold, but I see risk of further downside until structural fundamentals improve," he warns.
Viktoras Karapetjanc, expert at Traders Union, sees recent corporate actions as positioning Reckitt Benckiser for renewed growth. He highlights the proactive tender offer and covenant amendments as streamlining the company’s balance sheet and reinforcing confidence in management strategy. Moving averages and bullish momentum indicators support a constructive outlook, with potential for a decisive move above resistance. "The bullish structure remains intact and I expect further strength as the market rewards operational clarity," he says.
Jainam Mehta, market strategist, points to a mixed technical landscape for RKT. He notes that bullish momentum and overbought signals may create conditions for a tactical fade or a quick breakout if GBX5,274 is cleared. The narrow intraday range and volatility show indecisive sentiment that could reverse quickly on new flows. "A potential breakout above resistance offers a tactical trade, but I’d guard against whipsaw moves near recent lows," Mehta advises.
Reckitt Benckiser asset chart
Reckitt Benckiser price dynamics. Source: TradingView.

Buyer presence persists as momentum diverges from resistance

RKT remains positioned above its 20-day (GBX5,106) and 50-day (GBX4,882) moving averages, but still below the 200-day (GBX5,540) threshold, reflecting technical support in the short to medium term against a backdrop of persistent longer-term weakness. The nearest support is at GBX5,228 (Ichimoku Kijun), with immediate resistance at GBX5,274, as the price trades within a confined intraday range near recent lows. Momentum indicators, including MACD and ADX, point to underlying buy signals, while RSI, Stochastic RSI, and CCI all hover in overbought territory. Bull/Bear Power reinforces active buyer presence but underscores overbought conditions. Intraday volatility is marked at 1.63%, with the stock closing near the session low after opening with a modest downside gap—signaling caution in a slightly overstretched market.

Previously it was reported that Reckitt Benckiser’s recent debt tender offer and new product approval suggested a cautiously constructive, yet technically constrained, outlook. The current setup reinforces this view, with heightened short-term support but ongoing longer-term weakness, making the areas just above GBX5,274 pivotal for any bullish breakout in the days ahead.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.